Additionally, the 36-month beta value for ALLO is 0.32. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 4
ALLO has 36-month beta value of 0.31. Analysts have mixed views on the stock, with 8 analysts rating it as a “buy,” 5 as “overweight,”
Allogene Therapeutics Inc (NASDAQ: ALLO)’s stock price has soared by 1.89 in relation to previous closing price of 1.06. Nevertheless, the company has seen a
Allogene Therapeutics Inc (NASDAQ: ALLO)’s stock price has decreased by -1.80 compared to its previous closing price of 1.11. However, the company has seen a
The stock of Allogene Therapeutics Inc (ALLO) has gone down by -14.92% for the week, with a -24.90% drop in the past month and a
© 2024, Powered by Smart TechOne